EPM Scientific Deutschland

Pharmacovigilance Careers in Germany – Identifying Innovative Solutions to Hiring Challenges

Research by the World Health Organisation has found that more than half of all medicines are being prescribed, dispensed or sold incorrectly. Not only that but 50% of patients don’t take the medication they have been prescribed properly. In a time of global shortages when pharmaceutical resources could be crucial, the pharmacovigilance industry is more important than ever before.

 

Berlin, Germany -- (SBWIRE) -- 08/03/2020 -- Research by the World Health Organisation has found that more than half of all medicines are being prescribed, dispensed or sold incorrectly. Not only that but 50% of patients don't take the medication they have been prescribed properly. In a time of global shortages when pharmaceutical resources could be crucial, the pharmacovigilance industry is more important than ever before.

Opportunities in pharmacovigilance careers in Germany exist across the country, from Hamburg and Munich to Frankfurt, Berlin and Cologne. With the German Medicines Act providing a firm infrastructure for the way that information is handled for finished products on the market in Germany, there is already a broad awareness of the importance of pharmacovigilance work. From Berlin and Hamburg to Munich, Frankfurt and Cologne, gathering information about adverse drug reactions and interactions to help ensure awareness and mitigation of risks is crucial to the effectiveness of medicines.

EPM Scientific DE is a leading specialist recruiter to the Life Sciences sector and works with candidates with pharmacovigilance expertise, as well as the organisations looking to employ them. The firm was established in 2012 and has spent years nurturing relationships across the sector, partnering with engineers, advisors, scientists and directors from the most exceptional businesses within the Life Sciences sector. The firm has also established a nationwide network of talented people working at all levels of pharmacovigilance and has become a trusted recruitment partner to both individuals and organisations alike.

The global pharmacovigilance market has seen strong growth in recent years. While the impact of COVID-19 has been felt negatively by many sectors, those related to medical practice and medicine have been under pressure to evolve and respond to the current crisis in order to help manage it. Recent estimates forecast that the pharmacovigilance market could be worth €9.5bn by 2026, before the impact of COVID-19 has even been factored in. While a global pandemic may be a potential growth factor for some markets it's also presenting issues with respect to hiring, particularly where social distancing and isolation requirements remain in place. EPM Scientific DE is working with organisations across the industry to help support innovative solutions to existing hiring challenges and identify opportunities to support progress. The firm is a global specialist recruitment company, part of a network that covers 60+ countries worldwide, bringing a truly global perspective to the topic of pharmacovigilance in Germany.

"During uncertain times, EPM Scientific DE offers reassurance. Crises come in many different forms – financial crashes, oil gluts, and now a global pandemic". commented Luis Rolm, Global Marketing Director at EPM Scientific DE. He went on to say, "Yet, whatever the challenge, we remain steadfast in our service. We continue to offer guidance to clients in the Life Science sector and help them secure top talent."

To find out more information about Pharmacovigilance Careers in Germany visit https://www.epmscientific.de/disciplines/safety-pharmacovigilance.

For any media enquiries please contact Gary Elliott at Iconic Digital – 020 7100 0726.

For all other enquiries please contact EPM Scientific DE: +49 30 72 62 11 444.

For more information about EPM Scientific DE services, please go to https://www.epmscientific.de.

About EPM Scientific DE
EPM Scientific DE partners with organisations across the fast expanding pharmacovigilance sector. The firm's 750+ employees support growth and development among enterprises where innovation and insight will be crucial to both current and future generations.